BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16137834)

  • 1. Smoking status of Australian general practice patients and their attempts to quit.
    Doran CM; Valenti L; Robinson M; Britt H; Mattick RP
    Addict Behav; 2006 May; 31(5):758-66. PubMed ID: 16137834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour.
    Hammond D; McDonald PW; Fong GT; Borland R
    Addiction; 2004 Aug; 99(8):1042-8. PubMed ID: 15265101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and prevalence of hardcore smokers attending UK general practitioners.
    MacIntosh H; Coleman T
    BMC Fam Pract; 2006 Mar; 7():24. PubMed ID: 16571119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of snus in initiation and cessation of tobacco smoking in Sweden.
    Ramström LM; Foulds J
    Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aids to quitting tobacco use: how important are they outside controlled trials?
    Solberg LI; Boyle RG; Davidson G; Magnan S; Link Carlson C; Alesci NL
    Prev Med; 2001 Jul; 33(1):53-8. PubMed ID: 11482996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of proactively identifying smokers and offering smoking cessation support in primary care populations: a cluster-randomized trial.
    Murray RL; Coleman T; Antoniak M; Stocks J; Fergus A; Britton J; Lewis SA
    Addiction; 2008 Jun; 103(6):998-1006; discussion 1007-8. PubMed ID: 18422823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking patterns and readiness to quit--a study of the Australian Arabic community.
    Girgis S; Adily A; Velasco MJ; Garden FL; Zwar NA; Jalaludin BB; Ward JE
    Aust Fam Physician; 2009 Mar; 38(3):154-61. PubMed ID: 19283257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.
    Wilkes S; Evans A; Henderson M; Gibson J
    Postgrad Med J; 2005 Nov; 81(961):719-22. PubMed ID: 16272237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking, smoking cessation, and use of smoking cessation aids and support services in South Derbyshire, England.
    Edwards R; McElduff P; Jenner D; Heller RF; Langley J
    Public Health; 2007 May; 121(5):321-32. PubMed ID: 17339045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt.
    Johnstone E; Hey K; Drury M; Roberts S; Welch S; Walton R; Murphy M
    Addict Biol; 2004; 9(3-4):227-32. PubMed ID: 15511717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirometry and smoking cessation advice in general practice: a randomised clinical trial.
    Buffels J; Degryse J; Decramer M; Heyrman J
    Respir Med; 2006 Nov; 100(11):2012-7. PubMed ID: 16580189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illicit drug use as a predictor of smoking cessation treatment outcome.
    Stapleton JA; Keaney F; Sutherland G
    Nicotine Tob Res; 2009 Jun; 11(6):685-9. PubMed ID: 19395684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
    Kotz D; Wagena EJ; Wesseling G
    Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
    Steinberg MB; Foulds J; Richardson DL; Burke MV; Shah P
    Prev Med; 2006 Feb; 42(2):114-9. PubMed ID: 16375954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding smoking cessation: the role of smokers' quit history.
    Yzer MC; van den Putte B
    Psychol Addict Behav; 2006 Sep; 20(3):356-61. PubMed ID: 16938076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of smoking-cessation treatments in the United States.
    Shiffman S; Brockwell SE; Pillitteri JL; Gitchell JG
    Am J Prev Med; 2008 Feb; 34(2):102-11. PubMed ID: 18201639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.